Molecular modeling and dynamics studies of purine nucleoside phosphorylase from Bacteroides fragilis

被引:0
作者
Ivani Pauli
Luis Fernando Saraiva Macedo Timmers
Rafael Andrade Caceres
Luiz Augusto Basso
Diógenes Santiago Santos
Walter Filgueira de Azevedo Jr.
机构
[1] Pontifícia Universidade Católica do Rio Grande do Sul,Laboratório de Bioquímica Estrutural, Faculdade de Biociências
[2] Pontifícia Universidade Católica do Rio Grande do Sul,Programa de Pós
[3] Pontifícia Universidade Católica do Rio Grande do Sul,Graduação em Medicina e Ciências da Saúde
来源
Journal of Molecular Modeling | 2009年 / 15卷
关键词
Bioinformatics; Drug-design; Molecular dynamics; Molecular modeling;
D O I
暂无
中图分类号
学科分类号
摘要
Purine nucleoside phosphorylase (PNP) catalyzes the reversible phosphorolysis of N-ribosidic bonds of purine nucleosides and deoxynucleosides, except adenosine, to generate ribose 1-phosphate and the purine base. This work describes for the first time a structural model of PNP from Bacteroides fragilis (Bf). We modeled the complexes of BfPNP with six different ligands in order to determine the structural basis for specificity of these ligands against BfPNP. Comparative analysis of the model of BfPNP and the structure of HsPNP allowed identification of structural features responsible for differences in the computationally determined ligand affinities. The molecular dynamics (MD) simulation was assessed to evaluate the overall stability of the BfPNP model. The superposition of the final onto the initial minimized structure shows that there are no major conformational changes from the initial model, which is consistent with the relatively low root mean square deviation (RMSD). The results indicate that the structure of the model was stable during MD, and does not exhibit loosely structured loop regions or domain terminals.
引用
收藏
相关论文
共 271 条
[1]  
Myers LL(1987)undefined J Clin Microbiol 12 2330-2333
[2]  
Shoop DS(1980)undefined J Med Microbiol 13 231-245
[3]  
Stackhouse LL(1985)undefined J Clin Microbiol 21 472-473
[4]  
Newman FS(2007)undefined FEMS Microbiol Lett 272 15-21
[5]  
Flaherty RJ(1984)undefined Infect Immun 74 5382-5390
[6]  
Letson GW(1984)undefined Annu Rev Microbiol 38 293-313
[7]  
Sack RB(2004)undefined Mem Inst Oswaldo Cruz 99 319-324
[8]  
Duerden BI(2003)undefined Appl Environ Microbiol 69 6455-6463
[9]  
Collee JG(2007)undefined Curr Drugs Target 8 413-422
[10]  
Brown R(2008)undefined Bioorg Med Chem 16 4984-93